Thus, the neuroprotective features of TGF-β1 combined with its physiological activity on hippocampal synaptic plasticity and memory suggest that it might represent a new therapeutical strategy against neurodegenerative diseases characterized by an impairment of TGF-β signaling, such as AD. This evidence concerns the gene TGFB1 and neurodegenerative disease.